Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Lienhardt

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Antimicrobial Agents and Chemotherapy|July 15, 2024
Multi-year analysis of the global preclinical antibacterial pipeline: trends and gapsValeria Gigante, Richard A Alm, Daniela Melchiorri, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2022
Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is NeededMark S Butler, Valeria Gigante, Hatim Sati, et al.
Plos One|January 28, 2014
Randomised pharmacokinetic trial of rifabutin with lopinavir/ritonavir-antiretroviral therapy in patients with HIV-associated tuberculosis in VietnamNguyen Thi Ngoc Lan, Nguyen Thi Nguyet Thu, Aurélie Barrail-Tran, et al.
The New England Journal of Medicine|October 23, 2014
A four-month gatifloxacin-containing regimen for treating tuberculosisCorinne S Merle, Katherine Fielding, Omou Bah Sow, et al.
The Lancet. Public Health|July 1, 2023
Global, regional, and national estimates of tuberculosis incidence and case detection among incarcerated individuals from 2000 to 2019: a systematic analysisLeonardo Martinez, Joshua L Warren, Anthony D Harries, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
The potential impact, cost and cost-effectiveness of tuberculosis interventions - a modelling exerciseKatherine C Horton, Alvaro Schwalb, Martin J Harker, et al.
The Lancet. Global Health|December 26, 2018
Effect of the Bolsa Familia Programme on the outcome of tuberculosis treatment: a prospective cohort studyJanaina Gomes Nascimento Oliosi, Barbara Reis-Santos, Rodrigo Leite Locatelli, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 1, 2007
Cochrane systematic review of directly observed therapy for treating tuberculosis: good analysis of the wrong outcomeI D Rusen, Nadia Aït-Khaled, Edith Alarcón, et al.
Vaccine|February 15, 2022
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test caseSonali Kochhar, Draurio Barreira, Pauline Beattie, et al.
The Journal of Infectious Diseases|April 6, 2012
Clinical research and development of tuberculosis diagnostics: moving from silos to synergyPayam Nahid, Peter S Kim, Carlton A Evans, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Antimicrobial Agents and Chemotherapy|July 15, 2024
Multi-year analysis of the global preclinical antibacterial pipeline: trends and gapsValeria Gigante, Richard A Alm, Daniela Melchiorri, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2022
Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is NeededMark S Butler, Valeria Gigante, Hatim Sati, et al.
Plos One|January 28, 2014
Randomised pharmacokinetic trial of rifabutin with lopinavir/ritonavir-antiretroviral therapy in patients with HIV-associated tuberculosis in VietnamNguyen Thi Ngoc Lan, Nguyen Thi Nguyet Thu, Aurélie Barrail-Tran, et al.
The New England Journal of Medicine|October 23, 2014
A four-month gatifloxacin-containing regimen for treating tuberculosisCorinne S Merle, Katherine Fielding, Omou Bah Sow, et al.
The Lancet. Public Health|July 1, 2023
Global, regional, and national estimates of tuberculosis incidence and case detection among incarcerated individuals from 2000 to 2019: a systematic analysisLeonardo Martinez, Joshua L Warren, Anthony D Harries, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
The potential impact, cost and cost-effectiveness of tuberculosis interventions - a modelling exerciseKatherine C Horton, Alvaro Schwalb, Martin J Harker, et al.
The Lancet. Global Health|December 26, 2018
Effect of the Bolsa Familia Programme on the outcome of tuberculosis treatment: a prospective cohort studyJanaina Gomes Nascimento Oliosi, Barbara Reis-Santos, Rodrigo Leite Locatelli, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 1, 2007
Cochrane systematic review of directly observed therapy for treating tuberculosis: good analysis of the wrong outcomeI D Rusen, Nadia Aït-Khaled, Edith Alarcón, et al.
Vaccine|February 15, 2022
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test caseSonali Kochhar, Draurio Barreira, Pauline Beattie, et al.
The Journal of Infectious Diseases|April 6, 2012
Clinical research and development of tuberculosis diagnostics: moving from silos to synergyPayam Nahid, Peter S Kim, Carlton A Evans, et al.
Pageof 12